ADMA Biologics Stock Forecast - Naive Prediction

ADMA Stock  USD 21.18  0.12  0.56%   
The Naive Prediction forecasted value of ADMA Biologics on the next trading day is expected to be 18.24 with a mean absolute deviation of 0.74 and the sum of the absolute errors of 44.85. ADMA Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast ADMA Biologics stock prices and determine the direction of ADMA Biologics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of ADMA Biologics' historical fundamentals, such as revenue growth or operating cash flow patterns.
  
At present, ADMA Biologics' Inventory Turnover is projected to increase slightly based on the last few years of reporting. The current year's Payables Turnover is expected to grow to 11.40, whereas Fixed Asset Turnover is forecasted to decline to 2.45. . The current year's Common Stock Shares Outstanding is expected to grow to about 235.2 M, whereas Net Loss is forecasted to decline to (62.3 M).

ADMA Biologics Cash Forecast

Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the ADMA Biologics' financial statements to predict how it will affect future prices.
 
Cash  
First Reported
2006-09-30
Previous Quarter
88.2 M
Current Value
86.7 M
Quarterly Volatility
26.6 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
A naive forecasting model for ADMA Biologics is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of ADMA Biologics value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

ADMA Biologics Naive Prediction Price Forecast For the 26th of November

Given 90 days horizon, the Naive Prediction forecasted value of ADMA Biologics on the next trading day is expected to be 18.24 with a mean absolute deviation of 0.74, mean absolute percentage error of 1.00, and the sum of the absolute errors of 44.85.
Please note that although there have been many attempts to predict ADMA Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that ADMA Biologics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

ADMA Biologics Stock Forecast Pattern

Backtest ADMA BiologicsADMA Biologics Price PredictionBuy or Sell Advice 

ADMA Biologics Forecasted Value

In the context of forecasting ADMA Biologics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. ADMA Biologics' downside and upside margins for the forecasting period are 13.54 and 22.95, respectively. We have considered ADMA Biologics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
21.18
18.24
Expected Value
22.95
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of ADMA Biologics stock data series using in forecasting. Note that when a statistical model is used to represent ADMA Biologics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria118.1094
BiasArithmetic mean of the errors None
MADMean absolute deviation0.7353
MAPEMean absolute percentage error0.0387
SAESum of the absolute errors44.8548
This model is not at all useful as a medium-long range forecasting tool of ADMA Biologics. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict ADMA Biologics. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for ADMA Biologics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ADMA Biologics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
15.9720.6825.39
Details
Intrinsic
Valuation
LowRealHigh
6.7011.4123.30
Details
Bollinger
Band Projection (param)
LowMiddleHigh
19.0121.0723.12
Details
5 Analysts
Consensus
LowTargetHigh
5.466.006.66
Details

Other Forecasting Options for ADMA Biologics

For every potential investor in ADMA, whether a beginner or expert, ADMA Biologics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. ADMA Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in ADMA. Basic forecasting techniques help filter out the noise by identifying ADMA Biologics' price trends.

View ADMA Biologics Related Equities

 Risk & Return  Correlation

ADMA Biologics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of ADMA Biologics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of ADMA Biologics' current price.

ADMA Biologics Market Strength Events

Market strength indicators help investors to evaluate how ADMA Biologics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ADMA Biologics shares will generate the highest return on investment. By undertsting and applying ADMA Biologics stock market strength indicators, traders can identify ADMA Biologics entry and exit signals to maximize returns.

ADMA Biologics Risk Indicators

The analysis of ADMA Biologics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in ADMA Biologics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting adma stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether ADMA Biologics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ADMA Biologics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Adma Biologics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Adma Biologics Stock:
Check out Historical Fundamental Analysis of ADMA Biologics to cross-verify your projections.
For information on how to trade ADMA Stock refer to our How to Trade ADMA Stock guide.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ADMA Biologics. If investors know ADMA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ADMA Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
14
Earnings Share
0.27
Revenue Per Share
1.661
Quarterly Revenue Growth
0.781
Return On Assets
0.1989
The market value of ADMA Biologics is measured differently than its book value, which is the value of ADMA that is recorded on the company's balance sheet. Investors also form their own opinion of ADMA Biologics' value that differs from its market value or its book value, called intrinsic value, which is ADMA Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ADMA Biologics' market value can be influenced by many factors that don't directly affect ADMA Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ADMA Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if ADMA Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ADMA Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.